Urinary plasminogen activator activity in progressive renal failure
- PMID: 2271512
- PMCID: PMC4534997
- DOI: 10.3904/kjim.1990.5.1.58
Urinary plasminogen activator activity in progressive renal failure
Abstract
The purpose of this study was to discover how functional nephrons produce the plasminogen activator as renal function progresses to renal failure. Urine Plasminogen activator (U-PA) activity was measured by the fibrin plate method in 73 patients with various degrees of renal function deterioration from various underlying diseases and in one healthy individual in order to evaluate the plasminogen activator activity of remnant nephrons. The plasminogen activator activity of the 12 consecutive urine samples from the healthy individual showed that is varied according to the time of day, but there was no circadian rhythm. The urine plasminogen activator activity correlated with the osmolality (r = 0.51, P less than 0.001) and creatinine (r = 0.56, P less than 0.001) of the urine, suggesting that it is concentrated at distal nephrons. The fractional sodium excretion rate (FeNa) increased abruptly when GFR decreased below 25 L/day. This pattern was very similar with the relation between total U-PA activity/GFR and GFR. The correlation between total U-PA activity and FeNa was not significant, but there was a significant direct correlation between total U-PA activity/GFR and FeNa (r = 0.775, P less than 0.0001). There was no relationship between the 24-hour urine protein and total U-PA activity or total U-PA activity/GFR.(ABSTRACT TRUNCATED AT 250 WORDS)
Figures




Similar articles
-
[The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].Nihon Hinyokika Gakkai Zasshi. 1989 Nov;80(11):1558-65. doi: 10.5980/jpnjurol1989.80.1558. Nihon Hinyokika Gakkai Zasshi. 1989. PMID: 2512407 Japanese.
-
Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.Neth J Med. 1994 Jan;44(1):12-7. Neth J Med. 1994. PMID: 8202200
-
Glomerular and tubular factors in urine flow rates of acute renal failure patients.Am J Kidney Dis. 1994 Jun;23(6):788-93. doi: 10.1016/s0272-6386(12)80130-2. Am J Kidney Dis. 1994. PMID: 8203359
-
Phases of fluid and electrolyte homeostasis in the extremely low birth weight infant.Pediatrics. 1995 Sep;96(3 Pt 1):484-9. Pediatrics. 1995. PMID: 7651782
-
Influence of delivery on plasminogen activator inhibitor activity.J Perinat Med. 1989;17(2):107-11. doi: 10.1515/jpme.1989.17.2.107. J Perinat Med. 1989. PMID: 2681664 Review.
Cited by
-
The urine urokinase concentration in end stage renal disease with acquired renal cyst.Korean J Intern Med. 1991 Jul;6(2):64-8. doi: 10.3904/kjim.1991.6.2.64. Korean J Intern Med. 1991. PMID: 1807367 Free PMC article.
References
-
- Lesuk A, Terminiellol, Traver JH. Crystalline human urokinase: Some properties. Science. 1965;147:880. - PubMed
-
- White WF, Barlow GH, Mozen MM. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry. 1966;5:2160. - PubMed
-
- Bergstein JM, Michael AF., Jr Cortical fibrinolytic activity in normal and diseased human kidneys. J Lab Clin Med. 1972;79701 - PubMed
-
- Bergstein JM, Michael AF., Jr Renal cortical fibrinolytic activity in the rabbit following one or two doses of endotoxin. Thromb Diath Haemorrh. 1973;29:27. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous